1-8 of 8
Michael F. Quinn
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature

Michael A. Chapman, Jonathan Sive, John Ambrose, Claire Roddie, Nicholas Counsell, Anna Lach, Mahnaz Abbasian, Rakesh Popat, Jamie D. Cavenagh, Heather Oakervee, Matthew J. Streetly, Stephen Schey, Mickey Koh, Fenella Willis, Andres E. Virchis, Josephine Crowe, Michael F. Quinn, Gordon Cook, Charles R. Crawley, Guy Pratt, Mark Cook, Nivette Braganza, Toyin Adedayo, Paul Smith, Laura Clifton-Hadley, Roger G. Owen, Pieter Sonneveld, Jonathan J. Keats, Javier Herrero, Kwee Yong
Journal: Blood
Blood (2018) 132 (20): 2154–2165.
https://doi.org/10.1182/blood-2018-05-849893
Published: 2018
Includes: Supplemental data
Journal Articles

A Seven Gene Signature to Distinguish Bortezomib- and Lenalidomide-Responsive Myeloma: Rnaseq from the Padimac Study

Michael Chapman, PhD MRCP, FRCPath, Jonathan Sive, John Ambrose, Claire Roddie, PhD MD, Nicholas Counsell, Paul Smith, Nivette Braganza, Toyin Adedayo, Rakesh Popat, MD PhD, James D Cavenagh, Matthew J. Streetly, BMBS, PhD MRCP, FRCPath, Roger G. Owen, MD, Stephen Schey, MBBS, Mickey Koh, MD PhD, Josephine Crowe, Michael F. Quinn, FRCPath, MB, MD MRCP, Shirley D'Sa, MD FRCP, FRCPath, Andres E. Virchis, FRCP, FRCPath, Gordon Cook, PhD, Charles R Crawley, Guy Pratt, MD FRCP, FRCPath, Mark Cook, MBChB,PhD, Laura Clifton-Hadley, PhDBSc, Javier Herrero, PhD, Kwee Yong, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 267.
https://doi.org/10.1182/blood.V130.Suppl_1.267.267
Published: 2017
Journal Articles

Outcomes of Stratification to ASCT or Not Based on Depth of Response: Results of a Phase 2 Trial Assessing the Impact of Minimal Residual Disease (MRD) in Multiple Myeloma Patients with Deferred ASCT (PADIMAC)

Rakesh Popat, MD PhD, Ruth Mary De Tute, BSc,MSc, Nicholas Counsell, Dunnya De-Silva, Beth Phillips, MBBS, FRCPath, BSc, James D Cavenagh, Toyin Adedayo, Nivette Braganza, Claire Roddie, PhD MD, Mathew Streetly, Stephen Schey, MBBS, Mickey Koh, MD PhD, Josephine Crowe, Michael F. Quinn, FRCPath, MB, MD MRCP, Shirley D'Sa, MD FRCP, FRCPath, Andres E. Virchis, FRCP, FRCPath, Gordon Cook, PhD, Charles R Crawley, Guy Pratt, MD FRCP, FRCPath, Mark Cook, MBChB,PhD, Paul Smith, Laura Clifton-Hadley, PhDBSc, Neil Rabin, Roger G Owen, MD, Kwee Yong, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1864.
https://doi.org/10.1182/blood.V130.Suppl_1.1864.1864
Published: 2017
Journal Articles

RNA Sequencing of Newly Diagnosed Multiple Myeloma to Identify a Predictive Signature for Proteasome Inhibitor-Based Therapy

Jonathan I Sive, MDPhD, John C Ambrose, PhD, Kwee L Yong, Claire Roddie, MD PhD, Nicholas Counsell, Paul Smith, Nivette Braganca, Toyin Adadayo, Rakesh Popat, James D Cavenagh, MD, Roger G Owen, MDPhD, Matthew Streetly, Stephen A Schey, MD, Mickey Koh, MDPhD, Josephine Crowe, MD, Michael F Quinn, MD, Shirley D'Sa, Andres Virchis, MD, Gordon Cook, MDPhD, Charles Crawley, Guy E Pratt, MDFRCP FRCPath, Mark Cook, PhDMBChB, Michael A Chapman, MDPhD
Journal: Blood
Blood (2016) 128 (22): 3267.
https://doi.org/10.1182/blood.V128.22.3267.3267
Published: 2016
Journal Articles

Subcutaneous PAD As Induction Therapy for Patients with Newly Diagnosed Myeloma: A Phase 2 Trial Assessing the Impact of Minimal Residual Disease (MRD) in Patients with Deferred Autologous Stem Cell Transplantation (PADIMAC)

Rakesh Popat, James D Cavenagh, MD, Roger G Owen, MD, Matthew Streetly, Stephen A Schey, MD, Mickey Koh, MD, Josephine Crowe, Michael F. Quinn, FRCPath, MB, MD MRCP, Shirley D'Sa, MD FRCP, FRCPath, Andres Virchis, Gordon Cook, MD PhD, Charles Crawley, Guy Pratt, Mark Cook, PhD FRCPath, Heather E. Oakervee, MBBS, BSc, MD MRCP, FRCPath, Nicholas Counsell, Toyin Adedayo, Alison Evans, Nivette Braganca, Paul Smith, MSc, Janet lyons-Lewis, Neil Rabin, Kwee L Yong, MBChB, PhD
Journal: Blood
Blood (2014) 124 (21): 4745.
https://doi.org/10.1182/blood.V124.21.4745.4745
Published: 2014
Journal Articles

Analysis of HOXA5 and HOXB3 Expression Complements Conventional Cytogenetic Analysis in Acute Myeloid Leukemia.

Damian P.J. Finnegan, MRCP(UK), Vivien M. Hodges, PhD, Alexander Thompson, PhD, Michael F. Quinn, MD, Mervyn Humphries, PhD, Terence R.J. Lappin, PhD, Mary Frances McMullin, MD, Graham R. Ball, PhD
Journal: Blood
Blood (2007) 110 (11): 2388.
https://doi.org/10.1182/blood.V110.11.2388.2388
Published: 2007
Journal Articles

Artificial Neural Network Analysis of HOX Gene Expression Profiles Predicts Prognostic Subgroups in Acute Myeloid Leukemia.

Damian P.J. Finnegan, MRCP (UK), Michael F. Quinn, MD, Mervyn Humphreys, PhD, Terence R.J. Lappin, PhD, Mary Frances McMullin, MD, Alexander Thompson, PhD, Graham R. Ball, PhD
Journal: Blood
Blood (2006) 108 (11): 2318.
https://doi.org/10.1182/blood.V108.11.2318.2318
Published: 2006
Journal Articles

Global down-regulation of HOX gene expression in PML-RARα + acute promyelocytic leukemia identified by small-array real-time PCR

Alexander Thompson, Michael F. Quinn, David Grimwade, Claire M. O'Neill, Momin R. Ahmed, Sean Grimes, Mary Frances McMullin, Finbarr Cotter, Terence R. J. Lappin
Journal: Blood
Blood (2003) 101 (4): 1558–1565.
https://doi.org/10.1182/blood.V101.4.1558
Published: 2003